全喉切除术围手术期输血:一项全国性研究
基于NSQIP数据库2014至2022年2311例全喉切除术患者,413例(17.9%)接受输血。输血与住院时间延长(12天 vs 9天)、再手术率(23.2% vs 13.9%)和死亡率(2.7% vs 0.8%)升高相关,ROC分析提示输血>2.5单位与不良结局相关。
要点
- 全喉切除患者中17.9%接受围手术期输血,输血与住院时间、再手术和死亡率升高相关。
- 高血压、出血性疾病、ASA≥3、同期游离皮瓣和较低红细胞压积是多变量预测因素。
- ROC分析提示输血>2.5单位与不良结局相关,作者认为可能存在剂量依赖效应。
核心结论
- 全喉切除术仍是一项重大手术,可伴随漫长且复杂的住院过程。
- 围手术期输血可能与全喉切除患者住院时间延长、再手术和死亡率增加相关,并可能存在剂量依赖效应。
- 本研究强化了输血相关风险,并进一步支持在全喉切除患者中审慎使用血制品。
研究设计与样本
- 回顾性查询美国国家外科质量改进计划(NSQIP)数据库,纳入2014至2022年接受全喉切除伴或不伴颈淋巴结清扫(CPT 31360、31365)的患者。
- 输血总单位数仅对2020至2023年间的患者可获取。
- 统计分析包括假设检验、多变量逻辑回归和受试者工作特征(ROC)分析。
主要发现
- 2311例患者中413例(17.9%)接受输血。
- 非白人种族、ASA分级≥3、高血压、癌症伴远处转移、出血性疾病以及BUN、WBC和INR升高与输血相关(p<0.05)。
- 多变量分析确定高血压(OR 1.81)、出血性疾病(OR 2.64)、ASA≥3(OR 2.40)、同期游离皮瓣(OR 3.75)和较低红细胞压积(OR 0.85)为预测因素。
- 输血患者住院时间更长(12天 vs 9天),并发症增加(如卒中、深静脉血栓),再手术率更高(23.2% vs 13.9%),死亡率更高(2.7% vs 0.8%)(p<0.05)。
- ROC分析提示输血>2.5单位与不良结局相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Total laryngectomy (TL) represents a major operation often performed on medically complex patients. The impact of blood transfusion in TL patients is not well defined. Here, we utilize a national database to characterize these patients and further investigate a potential dose-dependent relationship between transfusion and postoperative outcomes. METHODS: The National Surgical Quality Program (NSQIP) was queried for patients who underwent TL with/without neck dissection (CPT 31360, 31365) between 2014 and 2022. Total units of transfused blood were only available for patients between 2020 and 2023. Statistical analysis involved hypothesis testing, multivariate logistic regression, and receiver operating characteristic (ROC) analysis. RESULTS: Among 2311 patients, 413 (17.9%) received transfusions. Non-White race, ASA Class ≥ 3, hypertension, cancer with distant metastases, bleeding disorders, and elevated BUN, WBC, and INR were associated with transfusion (p < 0.05). Multivariate analysis identified hypertension (OR 1.81), bleeding disorders (OR 2.64), ASA ≥ 3 (OR 2.40), concurrent free flap (OR 3.75) and lower hematocrit (OR 0.85) as predictors. Transfused patients had longer hospital stays (12 vs. 9 days), increased complications (e.g., stroke, DVT), higher reoperation (23.2% vs. 13.9%) and mortality (2.7% vs. 0.8%) (p < 0.05). ROC analysis suggested transfusion > 2.5 units was associated with adverse outcomes. CONCLUSION: TL remains a major surgical endeavor that can be associated with lengthy and complicated hospital courses. We show that perioperative transfusion may be associated with increased hospital stay, reoperation, and mortality in TL patients, with a potential dose-dependent effect. Our study reinforces the risks associated with blood transfusion and further supports the thoughtful utilization of blood products in TL patients.
引用
- Jategaonkar GA, Hintze JM, Xie DX, et al. Perioperative Transfusion Following Total Laryngectomy: A Nationwide Study. Laryngoscope. 2025. PMID: 40637378. doi:10.1002/lary.32392
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。